Regeneron Pharmaceuticals, Inc. (REGN): Total Assets
$40.56B
As of 2025-12-31
$41.73B
As of 2026-06-30
+11.6%
3-year compound annual growth
+18.8%
5-year compound annual growth
+21.9%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $40.56B | +7.4% | 2026-02-04, Balance as of period end |
| 2024-12-31 | $37.76B | +14.1% | 2026-02-04, Balance as of period end |
| 2023-12-31 | $33.08B | +13.2% | 2025-02-05, Balance as of period end |
| 2022-12-31 | $29.21B | +14.9% | 2024-02-05, Balance as of period end |
| 2021-12-31 | $25.43B | +48.2% | 2023-02-06, Balance as of period end |
| 2020-12-31 | $17.16B | +15.9% | 2022-02-07, Balance as of period end |
| 2019-12-31 | $14.81B | +26.2% | 2021-02-08, Balance as of period end |
| 2018-12-31 | $11.73B | +33.9% | 2020-02-07, Balance as of period end |
| 2017-12-31 | $8.76B | +25.7% | 2019-02-07, Balance as of period end |
| 2016-12-31 | $6.97B | +24.3% | 2018-02-08, Balance as of period end |
| 2015-12-31 | $5.61B | +46.2% | 2017-02-09, Balance as of period end |
| 2014-12-31 | $3.84B | +30.0% | 2016-02-11, Balance as of period end |
| 2013-12-31 | $2.95B | +41.8% | 2015-02-12, Balance as of period end |
| 2012-12-31 | $2.08B | +57.2% | 2014-02-13, Balance as of period end |
| 2011-12-31 | $1.32B | +21.5% | 2013-02-15, Balance as of period end |
| 2010-12-31 | $1.09B | +47.0% | 2012-02-21, Balance as of period end |
| 2009-12-31 | $741.20M | n/a | 2011-02-17, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $40.56B | +7.4% |
| Viatris Inc (VTRS) | 2025-12-31 | $37.19B | -10.4% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $25.64B | +13.8% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $40.75B | +3.6% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $26.37B | -0.6% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $15.47B | +8.6% |
| Organon & Co. (OGN) | 2025-12-31 | $12.87B | -1.8% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $8.19B | +38.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $13.36B | +5.9% |
Compare REGN, VTRS, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗